ArticleACS applied materials & interfaces2025
Versatile Polypeptide-Anchored Antifouling Dip-Coatings for Common Medical Implant Materials.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasound-activated piezoelectric Bi@Bi-MOF enables STING-mediated immunotherapy for implant-associated infections.Journal of nanobiotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Implant-associated infections represent a critical global healthcare challenge, exacerbated by recalcitrant biofilm formation and rising antimicrobial resistance. While antifouling polymer coatings could deter bacterial adhesion, common grafting methods such as surface-initiated polymerization face scalability and regulatory challenges. Dip-coating of antifouling polymers, facilitated by catechol-mediated anchorage to common medical implants, serves as a translationally appealing alternative. Although 3,4-dihydroxyphenylalanine (DOPA)-lysine-based oligopeptides were shown to exhibit mussel adhesive-like properties, they are not suitable for tethering high-molecular-weight (MW) antifouling polymers required for achieving adequate surface coverage. To facilitate unbiased screening for robust higher MW surface anchors, we synthesized a library of azide-terminated polypeptides─composed of DOPA alone or copolymerized with lysine, glutamate, or both randomly or in blocks in varying ratios─using N-carboxyanhydride ring-opening polymerization, achieving narrow polydispersity and excellent compositional control. These polypeptides were dip-coated onto Ti6Al4V and poly(ether ether ketone) substrates and conjugated with high-MW zwitterionic poly(sulfobetaine methacrylate) (pSBMA) by strain-promoted azide-alkyne cycloaddition. Using surface hydrophilicity as a readout of dip-coating efficiency and validated by X-ray photoelectron spectroscopy, we identified DOPA homopolymers as the optimal surface anchor for both substrates, significantly outperforming all copolymers containing lysine, glutamate, or both. The resulting pSBMA coatings resisted nonspecific protein adsorption or bacterial colonization and remained stable over one month in aqueous buffer at physiological pH and temperature. This DOPA homopolypeptide-mediated dip-coating strategy was also successfully extended to other implant substrates such as polyethylene terephthalate and silicone, establishing it as a potential universal implant surface modification approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.